Ausgabe 5/2023
Inhalt (15 Artikel)
Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial
- Open Access
- Summary of research
Robert J. Motzer, Paul Russo, Viktor Grünwald, Yoshihiko Tomita, Bogdan Zurawski, Omi Parikh, Sebastiano Buti, Philippe Barthélémy, Jeffrey C. Goh, Dingwei Ye, Alejo Lingua, Jean-Baptiste Lattouf, Laurence Albigès, Saby George, Brian Shuch, Jeffrey Sosman, Michael Staehler, Sergio Vázquez Estévez, Burcin Simsek, Julia Spiridigliozzi, Aleksander Chudnovsky, Axel Bex
Mutant HRas Signaling and Rationale for Use of Farnesyltransferase Inhibitors in Head and Neck Squamous Cell Carcinoma
- Review Article
Jiayu Wang, Dana Al-Majid, J. Chad Brenner, Joshua D. Smith
Clinical Efficacy and Safety of First- or Second-Generation EGFR-TKIs after Osimertinib Resistance for EGFR Mutated Lung Cancer: A Prospective Exploratory Study
- Original Research Article
Kenji Morimoto, Tadaaki Yamada, Takayuki Takeda, Shinsuke Shiotsu, Koji Date, Nobuyo Tamiya, Yasuhiro Goto, Hibiki Kanda, Yusuke Chihara, Yusuke Kunimatsu, Yuki Katayama, Masahiro Iwasaku, Shinsaku Tokuda, Koichi Takayama
Population Pharmacokinetics and Exposure–Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1
- Open Access
- Original Research Article
Xin Miao, Liviawati S. Wu, Shun Xin Wang Lin, Yan Xu, Yang Chen, Yuki Iwaki, Rachel Kobos, Tara Stephenson, Kristy Kemmerer, Clarissa M. Uhlar, Arnob Banerjee, Jenna D. Goldberg, Danielle Trancucci, Amit Apte, Raluca Verona, Lixia Pei, Rachit Desai, Kathleen Hickey, Yaming Su, Daniele Ouellet, Mahesh N. Samtani, Yue Guo, Alfred L. Garfall, Amrita Krishnan, Saad Z. Usmani, Honghui Zhou, Suzette Girgis
Population Pharmacokinetics and Pharmacodynamics of Carfilzomib in Combination with Rituximab, Ifosfamide, Carboplatin, and Etoposide in Adult Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma
- Original Research Article
Lan-Hsi Lin, Mohammad Ghasemi, Sarah M. Burke, Cory K. Mavis, Jenna R. Nichols, Pallawi Torka, Donald E. Mager, Francisco J. Hernandez-Ilizaliturri, Andrew K. L. Goey
Comparative Effectiveness of Lurbinectedin for the Treatment of Relapsed Small Cell Lung Cancer in the Post-Platinum Setting: A Real-World Canadian Synthetic Control Arm Analysis
- Original Research Article
Devon J. Boyne, David E. Dawe, Huma Shakir, Ofodile Joe-Uzuegbu, Eliya Farah, Aliyah Pabani, Cristina Baratta, Darren R. Brenner, Winson Y. Cheung
Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study
- Original Research Article
Seiichiro Mitani, Yosuke Kito, Kaori Hino, Kentaro Kawakami, Naoki Izawa, Fumiyasu Hanamura, Yoshiyuki Yamamoto, Hirokazu Shoji, Azusa Komori, Shogen Boku, Kenji Tsuchihashi, Kyoko Kato, Yoshikane Nonagase, Toshihiko Matsumoto, Mitsuhiro Furuta, Hisato Kawakami
Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer
- Original Research Article
Amandine Gouverneur, Clélia Favary, Jérémy Jové, Magali Rouyer, Emmanuelle Bignon, Francesco Salvo, Achille Tchalla, Elena Paillaud, Thomas Aparicio, Pernelle Noize
Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences
- Open Access
- Original Research Article
Jacqueline C. Barrientos, Ayed O. Ayed, Agnes Cha, Senxi Du, Bruno Fang, Ryan Hall, Stanley M. Marks, Eileen Peng, Joanna M. Rhodes, Kellie Ryan, Sharon B. Winters, Percy L. Yeung, Jing-Zhou Hou
Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly Diagnosed Multiple Myeloma Patients
- Original Research Article
Scott Jew, Sean Bujarski, Bernard Regidor, Marsiye Emamy-Sadr, Regina Swift, Benjamin Eades, Susanna Kim, Shahrooz Eshaghian, James R. Berenson
Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)
- Open Access
- Original Research Article
Hanno M. Witte, Jörg Riedl, Axel Künstner, Anke Fähnrich, Julius Ketzer, Stephanie M. J. Fliedner, Niklas Reimer, Veronica Bernard, Nikolas von Bubnoff, Hartmut Merz, Hauke Busch, Alfred Feller, Niklas Gebauer
A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich
- Open Access
- Original Research Article
Danmei Zhang, Klara Dorman, Kathrin Heinrich, Lena Weiss, Myrto Boukovala, Michael Haas, Philipp A. Greif, Frank Ziemann, Georg Beyer, Daniel Roessler, Elisabetta Goni, Bernhard Renz, Jan G. D’Haese, Wolfgang G. Kunz, Max Seidensticker, Stefanie Corradini, Maximilian Niyazi, Steffen Ormanns, Jörg Kumbrink, Andreas Jung, Andreas Mock, Martina Rudelius, Frederick Klauschen, Jens Werner, Julia Mayerle, Michael von Bergwelt-Baildon, Stefan Boeck, Volker Heinemann, C. Benedikt Westphalen
FDA Approvals of Oncology Drugs for Tissue-Agnostic Indications
- Original Research Article
Marjorie E. Zettler
Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate Cancer
- Open Access
- Adis Drug Evaluation
Arnold Lee
Correction to: Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate Cancer
- Open Access
- Correction
Arnold Lee
